BillionToOne , is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. The company's innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over 1,000-fold. This groundbreaking technology is integral to BillionToOne's product offerings. One of BillionToOne’s flagship products, Unity Complete , is the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, BillionToOne is expanding its reach into oncology with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. Over 500K patients have received BillionToOne tests to date, and BillionToOne has grown from $0M to $125M ARR in the last ~4 years.
Ranked at the top 5% of Y Combinator companies, BillionToOne has successfully raised close to $400 million in funding to date, with a notable $130 million Series D round completed in June 2024, resulting in an company evaluation of over $1 billion. This funding has come from prestigious global institutional investors, including Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024 , highlighting the company's exceptional work environment and commitment to innovation.
BillionToOne’s team has grown significantly and now proudly employs over 400 highly skilled individuals. Despite substantial growth, BillionToOne has successfully maintained the unique culture that defined us from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Northstar product and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit the company’s website at .
We are looking for passionate Clinical Laboratory Associates (CLA) to be responsible for assisting our day-to-day operations, providing equipment maintenance in the clinical laboratory, completing the pre-analytical phase of testing (e.g., specimen receipt, accessioning, and plasma/buffy coat isolation), performing quality assurance procedures, while complying with all local, state, and federal laboratory requirements. The Clinical Laboratory Associate (CLA) is an onsite position (Menlo Park) and provides a great opportunity for career growth - at BillionToOne, we offer an array of career growth opportunities and a clear growth tracks supported by ourperformance reviews (every 6 months).
Responsibilities:
Requirements:
Nice-To-Haves:
At BillionToOne, we are proud to offer a combination of (1) competitive base pay, (2) the opportunity for professional growth, and (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.).
For this position, the base pay rate is: $25 per hour.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Accepted file types: pdf, doc, docx, txt, rtf
Accepted file types: pdf, doc, docx, txt, rtf
LinkedIn Profile
Please provide your undergrad GPA: *
Please select which shift schedule(s) work best for you: *
Tuesday - Saturday AM - 7 AM - 3:30 PM
Sunday - Thursday AM - 7 AM - 3:30 PM
Monday - Friday Mid - 1 PM - 9:30 PM
Monday - Friday PM - 3 PM - 11 PM
Will you need sponsorship in order to work in the US? * Select...
#J-18808-Ljbffr